Xencor
XNCR
$24.42
Share price
3.34%
Change (1 day)
-7.57%
Change (1 year)
Categories
Xencor (XNCR) - Net assets
Net assets on the balance sheet as of December 2023 : $0.66 B
According to Xencor's latest financial reports the company has $0.66 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Xencor - Net assets on balance sheet (from 2012 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.66 B | -8.02% |
| 2022-12-31 | $0.72 B | -0.82% |
| 2021-12-31 | $0.73 B | 28.14% |
| 2020-12-31 | $0.57 B | -3.5% |
| 2019-12-31 | $0.59 B | 13.71% |
| 2018-12-31 | $0.52 B | 64.85% |
| 2017-12-31 | $0.31 B | 0.8% |
| 2016-12-31 | $0.31 B | 93.28% |
| 2015-12-31 | $0.16 B | 173.96% |
| 2014-12-31 | $59.29 M | -19.37% |
| 2013-12-31 | $73.53 M | -477.05% |
| 2012-12-31 | $-19.51 M | 78.31% |
| 2011-12-31 | $-10.94 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $68.77 B | 10,178.08% | 🇺🇸 USA |
 AbbVie ABBV | $10.39 B | 1,453.80% | 🇺🇸 USA |
 Amgen AMGN | $6.23 B | 831.35% | 🇺🇸 USA |
 Merck MRK | $37.63 B | 5,524.44% | 🇺🇸 USA |
 Seagen
SGEN | $2.55 B | 281.15% | 🇺🇸 USA |
 MacroGenics MGNX | $0.15 B | -77.19% | 🇺🇸 USA |